Pfizer Inc (NYSE:PFE)

34.44
Delayed Data
As of May 28
 +0.14 / +0.41%
Today’s Change
27.51
Today|||52-Week Range
35.53
+10.56%
Year-to-Date
Biotech group Cellectis in takeover talks with Pfizer
May 28 / FT.com
The 30 Dow Jones Stocks
May 18 / MotleyFool.com
Hedge Funds' 10 Most Shorted Stocks
May 27 / Benzinga
Immunomedics' Drug Gets Fast Track Status for Lung Cancer - Analyst Blog
May 18 / Zacks.com
3 Drug Stocks Prescribed for Portfolio Growth - Analyst Blog
May 27 / Zacks.com
Endo to buy Par from TPG Capital in in $8bn deal
May 18 / FT.com
3 Dow Stocks Hiding Weak Growth Prospects With Share Buybacks
May 26 / MotleyFool.com
4 Reasons Why MannKind Could Succeed Where Pfizer Failed
May 17 / MotleyFool.com
Pfizer and AstraZeneca: one year after deal that never was
May 26 / FT.com
Big Pharma Stocks: Where to Invest Your Money Now
May 17 / MotleyFool.com
Investors prepared to give Sir Andrew Witty time to revive GSK
May 24 / FT.com
The Botox initiation of Brent Saunders, Actavis chief executive
May 17 / FT.com
3 Stocks Poised to Grow in the Schizophrenia Market - Analyst Blog
May 22 / Zacks.com
Could an HIV/AIDS Vaccine Be a Reality By the End of the Decade?
May 16 / MotleyFool.com
MannKind, Front and Center: The Best Product Doesnbt Always Equal the Best Stock
May 21 / MotleyFool.com
GlycoMimetics' Leukemia Drug Gets Orphan Status in U.S. - Analyst Blog
May 15 / Zacks.com
Sarepta to Finish Eteplirsen Regulatory Filing by Mid-15 - Analyst Blog
May 20 / Zacks.com
The drugs to watch in fight against cancer
May 14 / FT.com
What Is the S&P 500 Index?
May 20 / MotleyFool.com
Top 50 US boardroom hoarders sit on $1tn in cash
May 10 / FT.com
Why Shares of Sarepta Therapeutics Skyrocketed Today
May 20 / MotleyFool.com
European drugmakers lifted by weak euro
Apr 30 / FT.com
Merck KGaA Q1 Earnings Fall Y/Y, 2015 Sales View Retained - Analyst Blog
May 19 / Zacks.com
Taubman lures more dealmakers to boutique
Apr 29 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account